Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT06040489
PHASE2/PHASE3
Pilot Study: Oral Treatment of American Tegumentary Leishmaniasis (Cutaneous and Mucosal Forms) in the Elderly
Sponsor: University of Brasilia
View on ClinicalTrials.gov
Summary
Randomised clinical trial comparing oral miltefosine associated with pentoxifylline to intravenous liposomal amphotericin b for the treatment of cutaneous and mucosal leishmaniasis
Key Details
Gender
All
Age Range
50 Years - Any
Study Type
INTERVENTIONAL
Enrollment
100
Start Date
2022-06-22
Completion Date
2026-06
Last Updated
2023-09-15
Healthy Volunteers
No
Interventions
DRUG
Miltefosine 50mg
Oral Miltefosine 50mg bid
DRUG
Pentoxifylline 400mg
Oral Pentoxifylline 400mg tid
DRUG
Liposomal Amphotericin B
Intravenous 25 to 40mg/kg
Locations (1)
Hospital Universitario de Brasilia
Brasília, Federal District, Brazil